Spot shows folks running as a symbol of how the health-challenged can chase their dreams because of Sanofi meds.

Objective To examine the associations between the number of days per week achieving various daily step thresholds and all-cause mortality and cardiovascular disease (CVD) incidence in older women.

Discover Regeneron’s Q3 2025 earnings: strong Dupixent, Libtayo & EYLEA HD growth, R&D updates, plus key manufacturing and regulatory challenges.

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights a pair of “timely and cool” stories on point-of-care AI use and the FDA approval of ...

With a new approach to creating thymus-targeted medicines for autoimmune diseases, Zag Bio has emerged from stealth with the ...

Sanofi India Limited ( ($IN:SANOFI) ) has shared an announcement. Sanofi India Limited has announced the appointment of Mr. Deepak Arora as the ...

Q3 2025 Earnings Call October 24, 2025 8:30 AM EDTCompany ParticipantsThomas Larsen - Head of Investor RelationsPaul Hudson - CEO ...

Pharmaceutical launches and increased demand for its blockbuster Dupixent drug lifted net sales by 7% in the third quarter.

Sanofi said new medicine generated sales of 1 billion euros, up 57% from the same period last year. It said sales of the anti-inflammatory treatment Dupixent--developed jointly with Regeneron--jumped ...